Charles P Meader

US Patent:

7547453, Jun 16, 2009

Filed:

Mar 30, 2007

Appl. No.:

11/694331

Inventors:

Charles P. Meader - Grover CO, US
Paul V. Christofferson - Draper UT, US

Assignee:

Equine Bio-Tech, Inc. - Grover CO

International Classification:

A61K 9/00
A61K 35/12
A61K 35/32

US Classification:

424537, 424520, 424548, 424400

Abstract:

Disclosed is a product and method for transplanting biological fluids into a host animal (including humans) that have been collected from donor animals. These biological fluids have been purified and processed so that they are acellular, sterile, pathogen free, and a form that can be stored for considerable periods of time without degradation. In one embodiment, synovial fluid is harvested from a large number of donors to produce the transplantation compound. Donor fluid is collected from a number of joints per animal, and initially screened for obvious abnormalities (clarity, color, viscosity. . . etc. ) and accepted or rejected on a joint-by-joint basis at the time of collection. The collected fluid is frozen in the field. Once in a laboratory setting, the fluid is warmed and spun down in a centrifuge. The supernate is collected, filtered, and mixed in large batches while the permeate is discarded.

US Patent:

7658950, Feb 9, 2010

Filed:

Mar 30, 2007

Appl. No.:

11/694254

Inventors:

Charles P. Meader - Grover CO, US
Paul V. Christofferson - Draper UT, US

Assignee:

Equine Bio-Tech, Inc. - Grover CO

International Classification:

A61K 9/00
A61K 35/12
A61K 35/32

US Classification:

424537, 424520, 424548, 424400

Abstract:

Disclosed is a product and method for transplanting biological fluids into a host animal (including humans) that have been collected from donor animals. These biological fluids have been purified and processed so that they are acellular, sterile, pathogen free, and a form that can be stored for considerable periods of time without degradation. In one embodiment, synovial fluid is harvested from a large number of donors to produce the transplantation compound. Donor fluid is collected from a number of joints per animal, and initially screened for obvious abnormalities (clarity, color, viscosity. . . etc. ) and accepted or rejected on a joint-by-joint basis at the time of collection. The collected fluid is frozen in the field. Once in a laboratory setting, the fluid is warmed and spun down in a centrifuge. The supernate is collected, filtered, and mixed in large batches while the permeate is discarded.

US Patent:

20060083787, Apr 20, 2006

Filed:

Dec 3, 2003

Appl. No.:

10/727893

Inventors:

Charles Meader - Grover CO, US
Paul Christofferson - Draper UT, US

International Classification:

A61K 35/12

US Classification:

424520000

Abstract:

Disclosed is a product and method for transplanting biological fluids into a host animal (including humans) that have been collected from donor animals. These biological fluids have been purified and processed so that they are a cellular, sterile, pathogen free, and a form that can be stored for considerable periods of time without degradation. In one embodiment, synovial fluid is harvested from a large number of donors to produce the transplantation compound. Donor fluid is collected from a number of joints per animal, and initially screened for obvious abnormalities (clarity, color, viscosity. . . etc.) and accepted or rejected on a joint-by-joint basis at the time of collection. The collected fluid is frozen in the field. Once in a laboratory setting, the fluid is warmed and spun down in a centrifuge. The supernate is collected, filtered, and mixed in large batches while the permeate is discarded. The supernate is re-frozen, lyophilized (freeze-dried) to form a cake and packaged as an individual dose under vacuum. The product is sterile, stable, has a long shelf life and can be readily reconstituted and injected into a joint.